To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
Labcorp added to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging.
The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive ...
Morning Overview on MSN
Why cancer returns years later, and how we can stop it
Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...
The Signatera assay showed positive correlations between ctDNA presence and cancer recurrence, suggesting its potential for ...
News-Medical.Net on MSN
Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...
In this analysis of the phase 3 ALLTO trial, researchers explored 10-year outcomes of HR+, HER2+ early breast cancer patients who received either an aromatase inhibitor or a selective estrogen ...
In this phase 3 trial, researchers aimed to study the efficacy of tumor bed boost and moderately hypofractionated whole breast irradiation in patients with non-low-risk DCIS.
MedPage Today on MSN
Gastric Cancer's Individualized Patient-Centered Treatment Approach
The only potentially curative options for gastric cancer involve endoscopic or surgical resection, with adjunctive systemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback